Home›Companies›Healthcare›Precision

Precision Neuroscience Corp

Develops brain-computer interfaces to help people with paralysis operate digital devices.

Updated Nov 9, 2026·Latest SEC filing Sep 28, 2026·Suggest an edit

About Precision

Precision is a private company based in New York, New York. It has reported $422,268,922 raised in five offerings on Form D since April 2021. Its chief executive is Michael Mager.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 11, 2026Sep 28, 2026$249,999,984target not set46$5.4MEquity, OptionsRule 506(b)Form D ↗
Oct 2, 2024Oct 17, 2024$93,118,915of $150.0M target21$4.4MEquity, Convertible Securities SharesRule 506(b)Form D ↗
Mar 26, 2024Apr 2, 2024$27,500,000of $45.0M target5$5.5MSafeRule 506(b)Form D ↗
Dec 5, 2022Dec 19, 2022amended Feb 1, 2023$41,150,023of $42.0M target20$2.0MEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 16, 2021Apr 28, 2021$10,500,000of $12.0M target2$5.2MEquityRule 506(b)Form D ↗
Total, five offerings$422,268,922

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Precision's Form D filed Sep 28, 2026.

Michael Mager
Michael Mager
Co-Founder & CEO, director
HM
RM
Ravi Mehta
Director
MG
CM
Craig Mermel
Chief AI and Data Officer, director
KA
Konstantinos Alataris
President and director
Also a director at Invicta Medical.
Benjamin Rapoport
Benjamin Rapoport
Co-Founder & Chief Science Officer, director
SB
MK
Michael Kaswan
Chief Financial Officer

Earlier filings also listed Jason Chen (director, last listed Oct 2024) and Eric Attias (director, last listed Oct 2024).

Sources

  1. SECPrecision Neuroscience Corp Form D, filed Dec 19, 2022
  2. SECPrecision Neuroscience Corp filing history
  3. CompanyPrivacy policy
  4. InvestorSCI Ventures portfolio: Precision Neuroscience